Photograph 49 is the Key to Understanding the History of Rosalind Franklin’s DNA Photograph 51
By Alistair Sponsel and Brian Sutton,
Springer Nature
| 10. 05. 2026
This essay, co-authored by a historian of science and an X-ray crystallographer, sheds new light on Rosalind Franklin’s Photograph 51. We refute the infamous claim that, unlike James Watson, Franklin failed to see the picture’s potential significance for interpreting the helical structure of DNA. Rather, Franklin decided to take Photograph 51 precisely because she knew that key parameters of DNA’s B form helix could be calculated from the resulting image. We show that she had in fact already made those calculations — on her earlier Photograph 49 — and she reused the same DNA sample for Photograph 51 to create a better-centered but otherwise identical diffraction image that would be suitable for publication. Thus Photograph 51 was not the result of an experiment in need of analysis, but was refined documentation for calculations that she had already performed on the earlier photograph. We argue that colleagues and later commentators did not merely overlook Franklin’s original reason for creating the strikingly clear and informative Photograph 51, they rhetorically erased her skill and judgment by describing it as though nature spoke for...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...